Preventing the Financing of Illegal Synthetic Drugs Act

Bill 118 HR 1076, also known as the Preventing the Financing of Illegal Synthetic Drugs Act, aims to address the issue of illegal synthetic drugs by targeting the financial networks that support their production and distribution. The bill was introduced in the House of Representatives on February 25, 2021, by Representative David Trone from Maryland.

The main provisions of the bill include increasing penalties for individuals and entities involved in the financing of illegal synthetic drugs, such as fentanyl and other dangerous substances. It also seeks to enhance coordination between federal agencies, such as the Department of Justice and the Department of the Treasury, to better track and disrupt the flow of funds to these illicit drug operations.

Furthermore, the bill calls for the establishment of a task force dedicated to investigating and prosecuting those involved in the financial aspects of the illegal synthetic drug trade. This task force would work closely with law enforcement agencies at the federal, state, and local levels to target and dismantle these criminal networks. Overall, the Preventing the Financing of Illegal Synthetic Drugs Act aims to disrupt the financial infrastructure that supports the production and distribution of dangerous synthetic drugs, ultimately working towards reducing the availability and harm caused by these substances in communities across the United States.